Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...

Research shows that eating a plant-based diet may offer protective benefits for heart health and prevention against certain ...

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for patients with prostate cancer.

Cleveland Clinic has formed a new Center for Genitourinary (GU) Malignancies Research, which will focus on advancing discoveries to better understand, diagnose and treat cancer of the prostate, ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced the recipients of its 2024 Challenge Awards, funding over $16 million in innovative prostate cancer research for ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced that its 2024 Young Investigator program has awarded a total of $6.3 million in funding to 30 promising next-generation ...

North East patients are among the first in the UK to trial Lutetium (177Lu) rhPSMA-10.1, a new targeted treatment for advanced prostate cancer resistant to hormone therapy.

A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...

ETHealthworld.com brings latest prostate cancer news, views and updates from all top sources for the Indian Health industry.